Tarsus Pharmaceuticals President, CEO and Board Chair Bobak R. Azamian sold 10,000 shares at $80.06 per share on Sep. 2, 2026. After the transaction, Azamian owned 837,991 shares, giving investors the reported size, price and remaining shareholding tied to the insider transaction.

Key Highlights

  • The transaction occurred on Sep. 2, 2026.
  • Bobak R. Azamian owned 837,991 shares after the sale.
  • Azamian serves as Tarsus Pharmaceuticals’ President, CEO and Board Chair.

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) saw President, CEO and Board Chair Bobak R. Azamian sell 10,000 shares at $80.06 per share. The transaction was completed on Sep. 2, 2026.

$80.06 Per-Share Insider Sale

Azamian’s transaction was recorded under code S. The sale took place while he served as Tarsus Pharmaceuticals’ President, CEO and Board Chair. Following the transaction, Azamian owned 837,991 shares of Tarsus Pharmaceuticals. The reported ownership figure represents Azamian’s ownership after the transaction. Tarsus Pharmaceuticals’ disclosure connects the sale to the specific per-share price of $80.06 and identifies Sep. 2, 2026, as the transaction date.